ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,000 | -86.5% | 173,798 | -7.3% | 0.00% | – |
| Q2 2021 | $244,000 | +64.9% | 187,431 | +75.5% | 0.00% | – |
| Q1 2021 | $148,000 | -39.6% | 106,806 | -44.2% | 0.00% | – |
| Q4 2020 | $245,000 | -31.6% | 191,375 | -48.5% | 0.00% | -100.0% |
| Q1 2020 | $358,000 | -76.3% | 371,576 | -32.8% | 0.00% | -50.0% |
| Q4 2019 | $1,510,000 | -20.9% | 553,046 | +14.1% | 0.00% | -33.3% |
| Q3 2019 | $1,909,000 | +44.0% | 484,625 | +48.8% | 0.00% | +50.0% |
| Q2 2019 | $1,326,000 | -53.6% | 325,717 | +48.5% | 0.00% | -50.0% |
| Q2 2018 | $2,858,000 | +181.6% | 219,351 | +138.2% | 0.00% | +300.0% |
| Q1 2018 | $1,015,000 | +351.1% | 92,079 | +311.9% | 0.00% | – |
| Q4 2017 | $225,000 | – | 22,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $24,309,000 | 36.46% |
| Pharmstandard International S.A. | 873,031 | $9,376,000 | 32.28% |
| TRV GP II, LLC | 2,790,964 | $29,975,000 | 17.60% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $35,768,000 | 6.55% |
| Partner Investment Management, L.P. | 301,889 | $3,242,000 | 2.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 295,199 | $3,170,000 | 0.36% |
| PFM Health Sciences, LP | 1,768,568 | $18,994,000 | 0.28% |
| Perceptive Advisors | 250,000 | $2,685,000 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 4,616 | $200,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $894,000 | 0.01% |